ElSohly; Mahmoud A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ElSohly; Mahmoud A..The latest application filed is for "selected artemisinin dimers for the treatment of lashmaniasis".

Company Profile

9.24.23

ElSohly; Mahmoud A. - Oxford MS

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selected Artemisinin Dimers For The Treatment Of Lashmaniasis App 20220175937 - ElSohly; Mahmoud A. ; et al.	2022-06-09
Biologically active cannabidiol analogs Grant 11,344,525 - ElSohly , et al. May 31, 2	2022-05-31
Biologically active cannabidiol analogs Grant 11,337,952 - ElSohly , et al. May 24, 2	2022-05-24
Biologically active cannabidiol analogs Grant 11,337,950 - ElSohly , et al. May 24, 2	2022-05-24
Biologically active cannabidiol analogs Grant 11,337,951 - ElSohly , et al. May 24, 2	2022-05-24
Isolation of pure cannabinoids from Cannabis Grant 11,117,852 - ElSohly , et al. September 14, 2	2021-09-14
Biologically Active Cannabidiol Analogs App 20210030708 - ElSohly; Mahmoud A. ; et al.	2021-02-04
Biologically Active Cannabidiol Analogs App 20200383944 - ElSohly; Mahmoud A. ; et al.	2020-12-10
Biologically Active Cannabidiol Analogs App 20200306217 - ElSohly; Mahmoud A. ; et al.	2020-10-01
Biologically Active Cannabidiol Analogs App 20200297687 - ElSohly; Mahmoud A. ; et al.	2020-09-24
Biologically Active Cannabidiol Analogs App 20200297688 - ElSohly; Mahmoud A. ; et al.	2020-09-24
Biologically active cannabidiol analogs Grant 10,709,681 - ElSohly , et al.	2020-07-14
Isolation of pure cannabinoids from Cannabis App 20200039908 - ElSohly; Mahmoud A. ; et al.	2020-02-06
Resveratrol Esters App 20190241498 - ElSohly; Mahmoud A. ; et al.	2019-08-08
Biologically Active Cannabidiol Analogs App 20190031601 - ElSohly; Mahmoud A. ; et al.	2019-01-31
Resveratrol esters Grant 10,099,995 - ElSohly , et al. October 16, 2	2018-10-16
Resveratrol Esters App 20170183290 - ElSohly; Mahmoud A. ; et al.	2017-06-29
Compositions containing delta-9-THC-amino acid esters and process of preparation Grant 9,630,941 - Elsohly , et al. April 25, 2	2017-04-25
Compositions for prevention/prophylactic treatment of poison ivy dermatitis Grant 9,408,822 - Elsohly , et al. August 9, 2	2016-08-09
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis App 20150202176 - ELSOHLY; Mahmoud A. ; et al.	2015-07-23
Compositions for prevention/prophylactic treatment of poison ivy dermatitis Grant 9,029,417 - Elsohly , et al. May 12, 2	2015-05-12
Compositions Containing Delta-9-thc-amino Acid Esters And Process Of Preparation App 20150045282 - ELSOHLY; Mahmoud A. ; et al.	2015-02-12
Compositions containing delta-9-THC-amino acid esters and process of preparation Grant 8,809,261 - Elsohly , et al. August 19, 2	2014-08-19
Compositions For Prevention/prophylactic Treatment Of Poison Ivy Dermatitis App 20130303582 - Elsohly; Mahmoud A. ; et al.	2013-11-14
Compositions for prevention/prophylactic treatment of poison ivy dermatitis Grant 8,486,998 - Elsohly , et al. July 16, 2	2013-07-16
Compositions Containing Delta-9-thc-amino Acid Esters And Process Of Preparation App 20110275555 - Elsohly; Mahmoud A. ; et al.	2011-11-10
Compositions For Prevention/prophylactic Treatment Of Poison Ivy Dermatitis App 20110086900 - Elsohly; Mahmoud A. ; et al.	2011-04-14
Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities Grant 7,842,720 - Elsohly , et al. November 30, 2	2010-11-30
Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities App 20080275106 - Elsohly; Mahmoud A. ; et al.	2008-11-06
Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents Grant 7,098,242 - ElSohly , et al. August 29, 2	2006-08-29
Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents App 20040266860 - ElSohly, Mahmoud A. ; et al.	2004-12-30
Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents App 20040229938 - ElSohly, Mahmoud A. ; et al.	2004-11-18
Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents Grant 6,790,863 - ElSohly , et al. September 14, 2	2004-09-14
Method of preparing delta-9-tetrahydrocannabinol Grant 6,730,519 - Elsohly , et al. May 4, 2	2004-05-04
Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents App 20040072896 - ElSohly, Mahmoud A. ; et al.	2004-04-15
Method of preparing delta-9-tetrahydrocannabinol App 20020086438 - Elsohly, Mahmoud A. ; et al.	2002-07-04
Method Of Preparing Delta-9-tetrahydrocannabinol App 20020039795 - ELSOHLY, MAHMOUD A. ; et al.	2002-04-04
Method of preparing delta-9-tetrahydrocannabinol Grant 6,365,416 - Elsohly , et al. April 2, 2	2002-04-02
Method of preparing delta-9-tetrahydrocannabinol esters Grant 6,008,383 - Elsohly , et al. December 28, 1	1999-12-28
Stable suppository formulations effecting bioavailability of .DELTA..sup.9 -thc Grant 5,389,375 - ElSohly February 14, 1	1995-02-14
Deuterated cannabinoids as standards for the analysis of tetrahydrocannabinol and its metabolites in biological fluids Grant 5,036,014 - ElSohly , et al.	1991-07-30
Method for effecting systemic delivery of delta-9-tetrahydrocannabinol Grant 4,933,363 - ElSohly June 12, 1	1990-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.